{"product_id":"global-breast-biopsy-market-size-study-forecast-by-product-vacuum-assisted-biopsy-core-needle-biopsy-fine-needle-aspiration-biopsy-by-image-guided-technology-mri-guided-breast-biopsy-ultrasound-guided-breast-biopsy-mammography-guided-stereotact","title":"Global Breast Biopsy Market Size study \u0026 Forecast, by Product (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy), by Image Guided Technology (MRI Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotact","description":"\u003cp\u003eGlobal Breast Biopsy Market Size study \u0026amp; Forecast, by Product (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy), by Image Guided Technology (MRI Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, CT Guided Biopsy), by End User (Hospitals and Clinics, Diagnostic Centers) and Regional Analysis, 2022-2029\u003c\/p\u003e\n\n\u003cp\u003eGlobal Breast Biopsy Market is valued at approximately USD 691.74 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1 % over the forecast period 2022-2029. Breast biopsies can also be used to test for other disorders that are found during a physical examination, however, they are most frequently used to identify breast cancer. Several methods can be used to segment the Breast Biopsy market. One of the least intrusive treatments available, fine needle aspiration biopsy, leaves no scars and is frequently used for breast biopsies. To remove tissue, a needle is inserted into the dermal tissue of the breast. The alternative technique uses ultrasonic radiation to direct the biopsy. The increasing prevalence of breast cancer and the growing Geriatric Population are key factors driving the market growth.\u003c\/p\u003e\n\n\u003cp\u003eThe rising incidences of breast cancer are contributing towards the growth of the Global Breast Biopsy Market. For instance- as per Global Cancer Observatory estimates – in 2020, the total number of breast cancer cases worldwide was estimated at 2.26 million, and this number is projected to reach 2.67 million, and a further 3.03 million in 2040. Furthermore, the increasing number of geriatric individuals is another factor driving the market space. For instance - according to the World Bank Group, the world’s old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 million in 2050. Also, the availability of advantageous reimbursement policies as well as the growing emergence of the liquid biopsy procedures. However, the high Cost of Breast Biopsy procedures coupled with the lack of availability of screening services in developing economies hinders the market growth throughout the forecast period of 2022-2029.\u003c\/p\u003e\n\n\u003cp\u003eThe key regions considered for the Global Breast Biopsy Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the presence of robust healthcare infrastructure as well as increasing incidences of breast cancer in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing investment in healthcare infrastructure in the region would offer lucrative growth opportunities for the market over the forecast period.\u003c\/p\u003e\n\n\u003cp\u003eMajor market player included in this report are:\u003cbr\u003e\nZenalux Biomedical Inc.\u003cbr\u003e\nF. Hoffmann-La Roche Ltd.\u003cbr\u003e\nOncoCyte Corporation\u003cbr\u003e\nLaboratory Corporation of America Holdings (Labcorp)\u003cbr\u003e\nScion Medical Technologies LLC\u003cbr\u003e\nPlanmed Oy\u003cbr\u003e\nAurora Imaging Technology Inc.\u003cbr\u003e\nCarestream Health\u003cbr\u003e\nCardinal Health,\u003cbr\u003e\nPerkinElmer Inc.\u003c\/p\u003e\n\n\u003cp\u003eRecent Developments in the Market:\u003cbr\u003e\n? In March 2021, IZI Medical Products, LLC, one of the leading manufacturers of medical devices used in interventional radiology and interventional oncology procedure announced the launch of its new Quick-Core Auto Biopsy System for soft tissue biopsy.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Breast Biopsy Market Report Scope:\u003cbr\u003e\nHistorical Data 2019-2020-2021\u003cbr\u003e\nBase Year for Estimation 2021\u003cbr\u003e\nForecast period 2022-2029\u003cbr\u003e\nReport Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends\u003cbr\u003e\nSegments Covered Product, Image Guided Technology, End User, Region\u003cbr\u003e\nRegional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World\u003cbr\u003e\nCustomization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional \u0026amp; segment scope*\u003c\/p\u003e\n\n\u003cp\u003eThe objective of the study is to define market sizes of different segments \u0026amp; countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.\u003c\/p\u003e\n\n\u003cp\u003eThe report also caters detailed information about the crucial aspects such as driving factors \u0026amp; challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.\u003c\/p\u003e\n\n\u003cp\u003eThe detailed segments and sub-segment of the market are explained below:\u003c\/p\u003e\n\n\u003cp\u003eBy Product\u003cbr\u003e\nVacuum Assisted Biopsy\u003cbr\u003e\nCore Needle Biopsy\u003cbr\u003e\nFine Needle Aspiration Biopsy\u003cbr\u003e\nBy Image Guided Technology\u003cbr\u003e\nMRI Guided Breast Biopsy\u003cbr\u003e\nUltrasound Guided Breast Biopsy\u003cbr\u003e\nMammography Guided Stereotactic Biopsy\u003cbr\u003e\nCT Guided Biopsy\u003cbr\u003e\nBy End User\u003cbr\u003e\nHospitals And Clinics\u003cbr\u003e\nDiagnostic Centers\u003c\/p\u003e\n\n\u003cp\u003eBy Region:\u003cbr\u003e\nNorth America\u003cbr\u003e\nU.S.\u003cbr\u003e\nCanada\u003cbr\u003e\nEurope\u003cbr\u003e\nUK\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nSpain\u003cbr\u003e\nItaly\u003cbr\u003e\nROE\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nIndia\u003cbr\u003e\nJapan\u003cbr\u003e\nAustralia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nRoAPAC\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nRoLA\u003cbr\u003e\nRest of the World\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eZenalux Biomedical Inc.\u003cbr\u003e\nF. Hoffmann-La Roche Ltd.\u003cbr\u003e\nOncoCyte Corporation\u003cbr\u003e\nLaboratory Corporation of America Holdings (Labcorp)\u003cbr\u003e\nScion Medical Technologies LLC\u003cbr\u003e\nPlanmed Oy\u003cbr\u003e\nAurora Imaging Technology Inc.\u003cbr\u003e\nCarestream Health\u003cbr\u003e\nCardinal Health,\u003cbr\u003e\nPerkinElmer Inc.\u003c\/p\u003e\n\n\u003cp\u003ePlease note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ 200 Pages \/ MCW16235952","offer_id":47651395404082,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-breast-biopsy-market-size-study-forecast-by-product-vacuum-assisted-biopsy-core-needle-biopsy-fine-needle-aspiration-biopsy-by-image-guided-technology-mri-guided-breast-biopsy-ultrasound-guided-breast-biopsy-mammography-guided-stereotact","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}